STORY
4 days 2 outlets 4 reports running since 19.08

LATEST

Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
finance.yahoo.com  ·  23.08.2026 08:23

HOW IT DEVELOPED

  1. Moderna Soars as Vaccine-Drug Combo Slows Recurrence of Melanoma finance.yahoo.com  ·  20.08 06:01
  2. Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations finance.yahoo.com  ·  19.08 23:58
  3. mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say arstechnica.com  ·  19.08 18:53

More in this section

JetBlue has been losing money for years. It just charted a path to profitability.marketwatch.com · 27.10 US law firm Weil readies restructuring as options dwindle and partners exitft.com · 27.10 When will Anthropic go public? Here’s what to know about the IPO timeline.marketwatch.com · 27.10 EU pressures allies over looming Ukraine funding crunchft.com · 27.10 Boeing shares slump as planemaker falls behind schedule in 737 jet productionft.com · 27.10 US insurance regulators back down on credit ratings scrutinyft.com · 27.10

Other stories

Rusiya Britaniyanın müdafiə şirkətlərinin rəhbərlərinə sanksiyalar tətbiq edibazerbaijan · report.az 6 Reasons Why Your Outfit Isn’t Working—and How to Find Your Personal Stylehealth · glamour.com Wenger's 'daylight' offside trial unlikely to be extendedsport · bbc.co.uk Putin və Pezeşkian İran ətrafındakı vəziyyəti müzakirə ediblərazerbaijan · report.az Ərdoğan Makronla ikitərəfli münasibətləri və qlobal məsələləri müzakirə edibazerbaijan · apa.az Nets vs. Celtics odds, prediction, time: 2026 NBA picks for Tuesday, Oct. 27 by proven modelsport · cbssports.com